Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,751,110
-$512,641 QoQ
Shares Held
155,777
+2.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#718
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCALIBUR MANAGEMENT CORP holds $32,863,371 across 10 Drug Manufacturers - General names. PFE ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,287 | $9,469,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,387 | $6,731,729 | |
| 3 | PFE |
Pfizer Inc
This page
|
155,777 | $3,751,110 | |
| 4 | ABBV |
AbbVie Inc.
|
13,505 | $3,398,398 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,349 | $2,697,232 | |
| 6 | AMGN |
Amgen Inc
|
6,407 | $2,320,102 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,161 | $1,968,356 | |
| 8 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,751,110 | 155,777 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,263,751 | 151,843 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,756,912 | 150,880 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,711,620 | 145,668 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,637,139 | 150,047 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,833,409 | 151,279 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,075,963 | 153,636 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,699,219 | 162,378 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,598,121 | 164,336 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,474,576 | 161,246 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,555,153 | 158,220 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,249,152 | 158,250 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,662,364 | 154,372 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,266,961 | 153,602 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,871,898 | 153,628 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,750,898 | 154,271 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $8,011,041 | 152,795 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $8,021,140 | 154,938 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $9,200,875 | 155,815 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,753,688 | 157,026 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $6,257,885 | 159,803 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $5,683,472 | 156,872 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $5,583,377 | 151,681 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $5,704,312 | 155,431 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $5,385,401 | 164,691 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,286,334 | 161,959 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||